N/A
Completed N=6
Using Attentional Bias Modification to Address Trauma Symptoms
Source: ClinicalTrials.gov NCT02615717 ↗Enrolled (actual)
6
Serious AEs
—
Results posted
Feb 2017
Primary outcomePrimary: Clinician-Administered PTSD Scale (CAPS-5) — 10.3; 10.0 units on a scale
Summary
Threat-related attentional biases have been identified as a possible precursor to the onset and maintenance of posttraumatic stress disorder (PTSD). As a result, protocols such as Attention Bias Modification (ABM) have been developed and utilized to treat these attentional biases in adults diagnosed with PTSD. However, to-date, ABM protocols have not been examined for use specifically among victims of sexual assaults. Participants are 20 undergraduate women enrolled in a Midwest university. The efficacy of ABM in this population will be assessed, as will the relationship between ABM and PTSD symptom clusters and outcome variables such as anxiety and depression scores.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Clinician-Administered PTSD Scale (CAPS-5) |
10.3; 10.0 | — |
| SECONDARY PTSD Checklist (PCL-5) |
11.0; 10.0 | — |
| SECONDARY Patient Health Questionnaire (PHQ-9) |
5.3; 6.7 | — |
| SECONDARY Beck Anxiety Inventory (BAI) |
29.0; 29.0 | — |
Eligibility Criteria
Inclusion Criteria
- Female, 19+, have experienced at least one adult sexual trauma, and must currently be experiencing PTSD symptoms as a result of the sexual assault
Exclusion Criteria
- male
Data sourced from ClinicalTrials.gov (NCT02615717). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.